Back to search

Article

The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysis

2023-08-16

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The dual-antiplatelet therapies (DAPT) of clopidogrel, prasugrel, or ticagrelor in concomitant use with acetylsalicylic acid are the contemporary treatment regimens for acute coronary syndromes (ACS). Systematic comparative effectiveness and safety analyses currently lack clinically meaningful interpretations of the summarized evidence. <h4>Methods</h4> We systematically searc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f88a01bd-caa9-56d1-bf0e-72c6fe603191
DOI
10.1101/2023.08.12.23294021
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysisDOI 10.1101/2023.08.12.23294021
Select a neighboring publication to make it the new centre.